封面
市場調查報告書
商品編碼
1391905

按次就診醫療市場:依產品類型、應用、配銷通路、地區

Per-Encounter Medical Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球按次就診醫療市場預計將顯著成長,預計到 2030 年將從 2023 年的 1,161.2 億美元增至 3,278.4 億美元。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 1161.2億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 16.00% 2030年市場規模預測 3278.4億美元
圖 1. 2023 年依地區分類的按次就診醫療市場佔有率(%)
偶遇醫療市場-IMG1

依次就診的醫療服務是依次就診提供的醫療服務,而不是傳統的依次收費模式。這種方法透過為患者提供更具成本效益和便利的醫療選擇,正在徹底改變醫療保健格局。

由於各種因素,全球按次就診醫療市場正在顯著成長。患者擴大尋求更實惠的醫療保健選擇,而 Par Encounter 醫療服務提供了一種有吸引力的選擇。科技的進步使得遠距提供優質醫療照護成為可能,進一步增加了對就診醫療服務的需求。

市場動態:

全球面診醫療市場受到多個促進因素的支持。首先,急劇上升的醫療成本促使患者尋求經濟上可行的替代治療方法。透明的定價使患者只需為他們需要的服務付費,使醫療保健更容易獲得。此外,慢性病的增加和人口高齡化也增加了對非處方醫療服務的需求。癌症和末期腎臟病等需要長期治療(透析和化療)的疾病的盛行率不斷增加,預計將推動市場成長。例如,根據癌症事實與數據報告,2022 年 1 月,美國癌症協會發布了美國估計有 190 萬例新癌症診斷和 609,360 例死亡。

但市場也存在抑制因素。缺乏保險報銷政策以及缺乏標準化的法規和政策可能會阻礙個人化醫療市場的成長。人們也可能擔心護理的品質和連續性,因為重點是間歇性護理而不是全面的醫療管理。

儘管存在這些課題,家庭醫療保健市場仍存在充足的機會。遠端醫療和遠端監控技術的日益普及提供了擴展的潛力。這些技術使醫療保健提供者能夠到達服務不足的地區並虛擬提供醫療保健服務,從而促進按次就診醫療服務的成長。此外,醫療保健提供者和保險公司之間的合作將有助於解決報銷問題並推動市場成長。

本研究的主要特點

  • 本報告對全球依次就診醫療市場進行了詳細分析,並列出了以2022年為基準年的預測期(2023-2030)的市場規模和復合年成長率。
  • 它還揭示了各個區隔市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數,介紹了全球 Par Encounter Medical 市場的主要參與者。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 本研究報告針對該產業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球一次性醫療市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 慢性病盛行率上升
    • 嚴格的監管要求
    • 拓展新興市場
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章全球按次就診醫療市場 –冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球依次醫療市場,依產品類型,2018-2030

  • 消耗品
  • 裝置
  • 軟體
  • 服務
  • 其他

第6章 全球依次就診醫療市場(依應用),2018-2030 年

  • 心臟病學
  • 整形外科
  • 婦產科
  • 眼科
  • 消化內科
  • 其他

第 7 章 全球依次就診醫療市場(依配銷通路),2018-2030 年

  • 直接競標
  • 零售
  • 線上銷售

第 8 章 全球依次就診醫療市場(依地區),2018-2030 年

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第9章競爭形勢

  • 公司簡介
    • Catalent Inc.
    • Smiths Medical Inc.
    • Cardinal Health
    • Schott
    • Nipro Corporation
    • Terumo Corporation
    • Gerresheimer AG
    • Becton, Dickinson and Company
    • Braun Melsungen AG
    • AngioDynamics Inc.
    • Teleflex Incorporated
    • Argon Medical Devices, Inc.
    • ICU Medical, Inc.
    • Medical Components, Inc.
    • Vygon(UK)Ltd

第10章

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6386

Global per-encounter medical market is expected to experience substantial growth, with an anticipated value of US$ 327.84 Bn by 2030, up from US$ 116.12 Bn in 2023.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 116.12 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 16.00% 2030 Value Projection: US$ 327.84 Bn
Figure 1. Per-Encounter Medical Market Share (%), By Region, 2023
Per-Encounter Medical Market - IMG1

Per-encounter medical services refer to medical treatments provided on a per-visit basis, rather than the traditional fee-for-service model. This approach is revolutionizing the healthcare landscape by offering more cost-effective and convenient care options for patients.

Global per-encounter medical market is experiencing considerable growth due to various factors. Patients are increasingly seeking more affordable healthcare options, and per-encounter medical services provide an attractive alternative. Advancements in technology have made it possible to deliver high-quality care remotely, further driving the demand for per-encounter medical services.

Market Dynamics:

Global per-encounter medical market is propelled by several drivers. Firstly, the rising healthcare costs are prompting patients to seek alternative care options that are economically viable. Per-encounter medical services offer transparent pricing and allow patients to pay only for the services they need, thus making healthcare more accessible. Moreover, the increasing prevalence of chronic diseases and the aging population further contribute to the demand for per-encounter medical services. Increasing prevalence of diseases such as cancer and end stage renal disease, which require longer duration therapies (dialysis and chemotherapy) is expected to drive the market growth. For instance, in January 2022according to data published in the Cancer Facts & Figures report by the American Cancer Society, , around 1.9 million new cancer cases was estimated to be diagnosed and 609,360 cancer deaths were reported in the U.S.

However, the market also has restraints. Lack of reimbursement policies and the absence of standardized regulations can hinder the growth of the per-encounter medical market. There may be concerns regarding the quality and continuity of care, as per-encounter medical services focus more on episodic care rather than comprehensive medical management.

Despite these challenges, the per-encounter medical market presents ample opportunities. The growing adoption of telemedicine and remote monitoring technologies provide a potential avenue for expansion. These technologies enable healthcare providers to reach underserved areas and offer healthcare services virtually, thereby fostering the growth of per-encounter medical services. Furthermore, collaborations between healthcare providers and insurance companies can help address reimbursement concerns and drive market growth.

Key features of the study:

  • This report provides in-depth analysis of the global per-encounter medical market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global per-encounter medical market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., and Vygon (UK) Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global per-encounter medical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global per-encounter medical market

Detailed Segmentation:

  • Global Per-Encounter Medical Market, By Product Type
    • Consumables
    • Devices
    • Software
    • Services
    • Others
  • Global Per-Encounter Medical Market, By Application
    • Cardiology
    • Orthopedics
    • Obstetrics/Gynecology
    • Ophthalmology
    • Gastroenterology
    • Others
  • Global Per-Encounter Medical Market, By Distribution Channel
    • Direct Tender
    • Retail Sales
    • Online Sales
  • Global Per-Encounter Medical Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in Global Per-Encounter Medical Market
    • Catalent Inc.
    • Smiths Medical Inc.
    • Cardinal Health
    • Schott
    • Nipro Corporation
    • Terumo Corporation
    • Gerresheimer AG
    • Becton, Dickinson and Company
    • B.Braun Melsungen AG
    • AngioDynamics Inc.
    • Teleflex Incorporated
    • Argon Medical Devices, Inc.
    • ICU Medical, Inc.
    • Medical Components, Inc.
    • Vygon (UK) Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of chronic diseases
    • Stringent regulatory requirements
    • Emerging markets expansion
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Per-Encounter Medical Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Per-Encounter Medical Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Per-Encounter Medical Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Obstetrics/Gynecology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Gastroenterology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Per-Encounter Medical Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Direct Tender
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Per-Encounter Medical Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Company Profile
    • Catalent Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Smiths Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Schott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nipro Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Gerresheimer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • AngioDynamics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Argon Medical Devices, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • ICU Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Medical Components, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Vygon (UK) Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us